HemoCue America HemoCue Glucose 201 Analyzer

The HemoCue Glucose 201 Analyzer is specifically engineered to minimize infection risks through its use of advanced microcuvette technology.

This technology creates a safer, closed system for handling blood samples, providing key benefits for both the professional and the patient:

• It significantly reduces the risk of infection and cross-contamination by completely containing the blood sample.
• It minimizes the need for direct manual handling of samples, contributing to a safer environment during rapid point-of-care testing.

Yes, the HemoCue Glucose 201 Analyzer holds CLIA-waived clearance.

This regulatory status is a crucial benefit for professional users, allowing the system to be utilized effectively in various point-of-care (POC) environments, including clinics, hospitals, and mobile units, while maintaining high standards.

Key advantages related to this clearance include:

• Simplified Compliance: Streamlines regulatory procedures for professional healthcare providers.
• Lab-Quality Accuracy: Provides precision required for professional diabetes diagnosis and monitoring.
• Rapid Performance: Delivers results quickly, within one minute, essential for timely patient management, including OGTT and screening newborns for hypoglycemia.

Yes, the HemoCue Glucose 201 Analyzer is a professional-grade, point-of-care system designed specifically for glucose testing critical to the diagnosis and ongoing management of diabetes. It provides lab-quality results quickly, enabling immediate clinical action.

Key features that support its use in professional healthcare settings include:

• Rapid Results: Delivers accurate glucose measurements in under one minute.
• Operational Simplicity: The system is factory-calibrated, eliminating the requirement for subsequent recalibration.
• Compliance Ready: It features CLIA-waived clearance.
• Versatility: Capable of performing Oral Glucose Tolerance Tests (OGTT) and specialized for detecting hypoglycemia in newborns.
• Portability and Safety: The unit is battery-operated for mobile use and utilizes microcuvette technology to reduce infection risk.

The HemoCue Glucose 201 Analyzer provides exceptionally rapid, lab-quality glucose measurements right at the point of care.

• Results are delivered consistently within 1 minute.

This quick turnaround time is vital for immediate clinical decision-making and supports essential procedures, including:

• Timely diagnosis and monitoring for effective glycemic control.
• The effective performance of Oral Glucose Tolerance Tests (OGTT).
• Rapid detection of critical conditions, such as hypoglycemia in newborns.

Yes, the HemoCue Glucose 201 Analyzer is highly suitable for neonatal screening and point-of-care use. It is specifically designed to assist in the diagnosis and monitoring of conditions such as hypoglycemia in newborns.

This professional-grade system provides critical advantages for sensitive testing environments:

• Lab-Quality Accuracy: Delivers the precision required for professional management and monitoring.
• Rapid Results: Provides reliable glucose readings within one minute, supporting timely clinical intervention.
• Enhanced Safety: Utilizes specialized microcuvette technology which reduces the risk of infection during patient testing.
• Maintenance-Free: The system is factory-calibrated, eliminating the need for ongoing recalibration and ensuring consistent performance.

No, the HemoCue Glucose 201 Analyzer is factory-calibrated. This key feature eliminates the need for routine recalibration, thereby removing administrative burden and potential downtime often associated with analyzer maintenance.

The HemoCue Glucose 201 Analyzer is offered in several configurations to meet diverse professional requirements:

• Analyzer Only: This option includes just the HemoCue Glucose 201 Analyzer (MPN: 120706).
• Analyzer with AC Adapter and Docking Station: This bundle (MPN: G1PROMO) includes the analyzer along with an AC adapter and docking station.
• Analyzer with Microcuvettes and Control Solutions: This package (MPN: GDMPPROMO) provides the analyzer, a box of 50 Glucose 201 Microcuvettes, and Eurotol Glucose Control Solution (one vial each of high and low).

Note: Configurations that include control solutions or certain accessories may be perishable and non-returnable, requiring refrigeration.

Yes, the HemoCue Glucose 201 Analyzer is capable of performing Oral Glucose Tolerance Tests (OGTT), making it versatile for various diagnostic needs in professional settings.

Yes, the HemoCue Glucose 201 Analyzer is a professional-grade system designed exclusively for point-of-care testing in healthcare settings like clinics, hospitals, and mobile units.

This analyzer provides lab-quality accuracy and holds CLIA-waived clearance, ensuring it meets regulatory standards for professional deployment.

Key professional applications include:

• Diabetes Diagnosis and Management: Supports standard monitoring and performs Oral Glucose Tolerance Tests (OGTT).
• Neonatal Assessment: Specifically capable of detecting hypoglycemia in newborns.
• Rapid Results: Delivers reliable glucose readings in just one minute, supporting timely clinical decisions.

Yes, the HemoCue Glucose 201 Analyzer is designed for excellent portability in point-of-care settings. It is compact and battery-operated, making it highly suitable for use in mobile and remote healthcare settings, clinics, and hospitals.